Jamie M. Iffland

**** ***** ********** **. ******** Valley, AZ. 310-***-**** ad4jp1@r.postjobfree.com

AWARD-WINNING KEY ACCOUNT MANAGER HEMATOLOGY ALLERGY RESPIRATORY

Multiple #1 & Top Rankings President’s Club Regional Field Sales Trainer

Product Launch: Diverse product launch expertise, President’s Club Winner (Hematology/ Rare Disease Product Launch Year). Nationally recognized, award-winning sales experience in precise patient identification of rare hematologic malignancies and patient access pull-through expertise.

Market Access & Reimbursement: Drive successful patient pull-through and created access during COVID-19 challenges, leveraging remote engagement to minimize access and reimbursement barriers for patients and providers.

KOL Development: Deep clinical acumen and expertise to manage and develop National Key Opinion Leaders.

SeaGen 10/2022 - 08/2023

Senior Oncology Account Manager

Institutions: Kaiser, UCLA, City of Hope, Cedars-Sinai, USC, Medical Oncology Community Clinics

Territory: Southern California

Products/Disease States: PADCEV, Infusion Nectin-4 Directed Antibody for Locally Advanced or Metastatic Bladder Cancer

Select Highlights:

Achieved measurable growth and 3 new prescribing accounts in current territory within 2 months.

Aggressively grew my territory to #1 ( out of 7) from #6 in 6 months with precise targeting and strategic business execution.

EISAI 08/2021 – 10/2022

Kaiser Account Executive, Market Access (Inaugural Kaiser Team)

Institutions: Kaiser

Territory: Southern California, Georgia, Mid-Atlantic

Products/Disease States: LENVIMA, Oral kinase inhibitor for Differentiated Thyroid Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma and Endometrial Carcinoma HALAVEN, microtubule inhibitor indicated for the treatment of Metastatic Breast Cancer

Select Highlights:

Align portfolio performance with organizational goals to drive access and sales through contracting and value discussions, customer equity, and cross-functional engagement.

Achieved 21% - 25% YoY growth (LENVIMA), 2021 – 2022.

Oversee strategic account and business planning by establishing measurable goals and inspiring collaboration with cross-functional HEOR and MSL teams to respond with a sense of urgency to customer needs.

TAKEDA ONCOLOGY 10/2015 – 08/2021

Oncology Territory Manager, Hematology Team

Institutions: UCLA, Cedars-Sinai, City of Hope, USC, Kaiser Woodland Hills, Kaiser Sunset, Kaiser West LA, Veterans Affairs.

Call Points: Hematology Academic KOL’s, BMT Institutional Teams, Hematology/Oncology Community Clinics

Territory: Beverly Hills, Santa Monica, San Fernando Valley, Ventura County

Products/Disease States: NINLARO, Oral Oncolytic 1st/ only Proteasome Inhibitor for Multiple Myeloma ICLUSIG, Chronic Myeloid Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) VELCADE, Multiple Myeloma

Select Highlights:

Aggressively grew current territory 37.42%, current year-to date in a virtual setting in a highly competitive, evolving market landscape.

Selected by Senior Management for Regional Field Sales Trainer 2019-2021 (National Leadership Position), to lead field sales clinical proficiency at a regional level and lead strategic nationwide training initiatives.

Selected by Senior Leadership for the Field Advisory Board 2018-2019, working directly with the NINLARO Brand Marketing team to develop new marketing initiatives, national patient educational speaker programs, KOL expanded speaking engagement opportunities, advisory board leadership participation and marketing collateral development.

Ranked #1 (of 22) Kaiser Territories, including prescription Sales 2017.

Ranked #13 (of 85) 2017 Top 15%; Ranked #9 (of 85) 2016 Top 10%.

President’s Club 2016 (NINLARO Product Launch Year).

Launched NINLARO, first and only oral Proteasome Inhibitor for Multiple Myeloma into a heavily competitive market space with 2 new Multiple Myeloma products approved in the same month, November 2015.

Laser focus on managing/navigating complex academic and hospital account environments while working with cross- functional partners, including National Account Directors, MSL, Nurse Educators, Marketing & Training Directors.

TEVA PHARMACEUTICALS 07/2014 - 10/2015

Executive Sales Specialist

Call Points: Oncology, Pain Management

Territory: Los Angeles, San Fernando Valley, Ventura County, Santa Barbara, Santa Maria, San Luis Obispo

Products/Disease States: FENTORA, Immediate Release Fentanyl-Breakthrough Cancer Pain, Oncology AMRIX, Muscle Relaxant

Select Highlights:

President’s Club 2015, increased territory ranking from #37(of 70) to #3 (of 70) in 12 months.

Ranked #1 (of 9) in district for AMRIX sales, growing market share over 30% in 12 months to achieve 115% to- goal.

Extensive specialty pharmacy collaboration and new patient access pull- through, achieving 127.5% to goal for FENTORA.

PURDUE PHARMACEUTICALS 09/2009 - 07/2014

Specialty Pharmaceutical Sales Representative

Institutions: Cedars-Sinai Medical Center and UCLA

Call Points: Pain Management, Neurology, Anesthesiology, Rheumatology, Oncology, Orthopedic Surgery, Psychiatry

Territory: Santa Monica, Beverly Hills, Los Angeles

Products/Disease States: OXYCONTIN, C2 Opioid for Chronic Pain BUTRANS, Buprenorphine Transdermal System for Chronic Pain INTERMEZZO, Insomnia RYZOLT, Tramadol for moderate to severe pain

Select Highlights:

Ranked #1 (of 9) district sales leader for BUTRANS total prescription sales, 2013 and 2014.

Ranked top 5% regionally for BUTRANS, Buprenorphine Transdermal System prescription sales, 2013 and 2014.

Nationally ranked #3 (of 525) and ranked #1 (of 52) regionally, INTERMEZZO prescription sales, 2013.

Ranked Top 10% (of 525) nationally for BUTRANS, 2011 and 2012.

Launched BUTRANS and RYZOLT in heavily restricted managed care environment and severe competition.

Identified and developed KOL’s for Oxycontin and BUTRANS including UCLA Pain Management Director and Co-Director of the Cedars Pain Management Center.

Within first three months of taking over highly competitive Beverly Hills territory, increased access to Cedars-Sinai Integrated Pain Management Health System.

UCB PHARMA 09/2003 - 09/2009

Pharmaceutical Sales Representative

Call Points: Allergy & Immunology, Psychiatry, Dermatology

Territory: Santa Monica, Beverly Hills, San Fernando Valley, Burbank, Glendale, Palmdale, Lancaster

Products/Disease States: ZYRTEC, Xyzal, Allergy PROAIR, Asthma TUSSIONEX, Respiratory Relief METADATE CD, ADHD

Select Highlights:

Launched Xyzal; beat the national average patient conversion rate (ZYRTEC to XYZAL) by 2% (5.6% vs. 3.6%), 2008-2009.

Selected by XYZAL product manager to deliver field sales training at the national level to combat high managed care restrictive territories, generic competition, and clinical proficiency.

Chosen by National Sales Director to participate in development of strategic business plans to increase retention.

Achieved 175% to- goal against (74% nationally), ProAir; 92% to- goal, TUSSIONEX against (77% nationally) 2008.

Bachelor of Arts in Broadcast Journalism, Business Minor, Arizona State University

P R O F E S S I O N A L E X P E R I E N C E

E D U C A T I O N

Contact this candidate